Rezolute (RZLT) Other financing activities (2012 - 2026)

Rezolute (RZLT) reported Other financing activities of $747000.0 for Q1 2026, up 109.83% sequentially from $356000.0 in Q4 2025.

Rezolute (RZLT) Other financing activities (2012 - 2026) Analysis & Trends

Rezolute (RZLT) has 7 years of Other financing activities data on file, last reported at $747000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $747000.0; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (down 65.68% YoY), and the FY2025 full-year result was $893000.0, up 281.62% from the prior year.
  • Other financing activities climbed to $747000.0 in Q1 2026, from $356000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $12.3 million in Q3 2022 to a low of $9997.0 in Q2 2025.
  • A 4-year average of $3.4 million and a median of $846500.0 in 2025 frame the typical range for Other financing activities.
  • Peak annual rise in Other financing activities reached 84.23% in 2025, while the deepest fall reached 84.23% in 2025.
  • Tracing RZLT's Other financing activities over 4 years: stood at $12.3 million in 2022, then sank by 51.34% to $6.0 million in 2024, then slumped by 94.07% to $356000.0 in 2025, then soared by 109.83% to $747000.0 in 2026.
  • Business Quant data shows RZLT's Other financing activities at $747000.0 in Q1 2026, $356000.0 in Q4 2025, and $946000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Rezolute 31,153.77 31,153.77 -

Historic Data

Download Data
DateValue
Mar 31, 2026 747,000.00
Mar 31, 2026 747,000.00
Dec 31, 2025 356,000.00
Dec 31, 2025 356,000.00
Sep 30, 2025 946,000.00
Sep 30, 2025 946,000.00
Jun 30, 2025 9,997.00
Jun 30, 2025 9,997.00
Sep 30, 2024 6.00 Mn
Sep 30, 2024 6.00 Mn
Sep 30, 2022 12.33 Mn
Sep 30, 2022 12.33 Mn
Mar 31, 2014 128,300.00
Mar 31, 2014 128,300.00
Dec 31, 2013 142,000.00
Dec 31, 2013 142,000.00
Jun 30, 2013 157,500.00
Jun 30, 2013 157,500.00
Mar 31, 2013 -145,000.00
Mar 31, 2013 -145,000.00